|
|
|
Serum Occludin as a Biomarker to Predict the Severity of Acute Ischemic Stroke, Hemorrhagic Transformation, and Patient Prognosis
|
|
Li Weili, Qi Zhifeng, Kang Huining, Qin Xuzhen, Song Haiqing, Sui Xueqin, Ren Yi, Ji Xunming, Ma Qingfeng, Jian Liu Ke
|
|
| |
| Table 1 Baseline Characteristics of admitted patients. |
|
| Variable | Stroke group
(n=207) | pseudo stroke
(n=36) |
|---|
| Age — yr | 65.6±13.2 | 58.2±14.2 | | Male sex — no. (%) | 143 (69.1) | 21 (58.3) | | Atrial fibrillation — no. (%) | 40 (19.3) | 2 (5.6) | | Coronary artery disease— no. (%) | 32 (15.5) | 4 (11.1) | | Diabetes mellitus — no. (%) | 60 (29.0) | 10 (27.8) | | Hypertension — no. (%) | 125 (60) | 22 (61.1) | | Previous stroke — no. (%) | 48 (23.2) | 12 (33.3) | | Median NIHSS score (IQR) | 4 (3-5) | 4 (2-7) | | SBP (mmHg) | 154.2±26.1 | 142.2±15.5 | | Median time from onset to puncture— hr (IQR) | 4 (2.1-7.5) | 3.8 (2.4-6.0) | | LDL-C (mmol/L) | 2.8±1.0 | 2.6±0.8 | | GLU (mol/L) | 8.0±3.9 | 7.6±3.1 | | FIB (g/L) | 3.6±1.1 | 3.6±1.0 | | Data were presented as means±SD or medians (IQR). |
|
|
|